10-Q Filing

LifeMD, Inc. CIK: 948320 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-008664`
Period End Date	20170630
Filing Date	20170814
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	immd-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 73 Cash Flow Statement 71 Stockholders Equity 24

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$235.45K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	41.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.57M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$436.09K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	217,391.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.66M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$444.74K	USD	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$519.62K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.25M	shares	Point-in-time
Treasury stock, common shares	`TreasuryStockCommonShares`	337,800.00	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$2.25K	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Treasury stock, common shares	`TreasuryStockCommonShares`	325,000.00	shares	Point-in-time
Product deposit	`DepositAssets`	$74.04K	USD	Point-in-time
Product deposit	`DepositAssets`	-	USD	Point-in-time
Inventory, net	`InventoryNet`	$160.27K	USD	Point-in-time
Inventory, net	`InventoryNet`	$127.45K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.16M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$789.82K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$561.83K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$752.93K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$192.25K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$955.01K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	$100.00K	USD	Point-in-time
Notes payable, net of discount in 2016	`NotesPayableCurrent`	$106.36K	USD	Point-in-time
Notes payable, net of discount in 2016	`NotesPayableCurrent`	$74.04K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.15M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.59M	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 40,995,763 and 35,570,157 shares issued, 40,657,963 and 35,245,157 outstanding as of June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$409.96K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 40,995,763 and 35,570,157 shares issued, 40,657,963 and 35,245,157 outstanding as of June 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$355.70K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.07M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.53M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-9.69M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-10.00M	USD	Point-in-time
Equity	`Equity`	$-59.18K	USD	Point-in-time
Equity	`Equity`	$-268.12K	USD	Point-in-time
Treasury stock, 337,800 and 325,000 shares, at cost	`TreasuryStockValue`	$87.05K	USD	Point-in-time
Treasury stock, 337,800 and 325,000 shares, at cost	`TreasuryStockValue`	$90.20K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$-149.38K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$-355.17K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-284.30K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-6.55K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Total Stockholders' (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-433.69K	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.16M	USD	Point-in-time
Total Liabilities and Stockholders' (Deficit)	`LiabilitiesAndStockholdersEquity`	$789.82K	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`Revenues`	$2.87M	USD	2 Qtrs
Net Sales	`Revenues`	$1.53M	USD	2 Qtrs
Net Sales	`Revenues`	$1.11M	USD	1 Quarter
Net Sales	`Revenues`	$1.23M	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$532.60K	USD	2 Qtrs
Cost of Sales	`CostOfRevenue`	$700.98K	USD	1 Quarter
Cost of Sales	`CostOfRevenue`	$2.04M	USD	2 Qtrs
Cost of Sales	`CostOfRevenue`	$329.25K	USD	1 Quarter
Gross Profit	`GrossProfit`	$526.27K	USD	1 Quarter
Gross Profit	`GrossProfit`	$778.17K	USD	1 Quarter
Gross Profit	`GrossProfit`	$829.36K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$999.28K	USD	2 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$475.06K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$243.96K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$602.44K	USD	2 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$715.51K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$121.95K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$221.58K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$194.67K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$125.36K	USD	1 Quarter
Marketing expenses	`MarketingExpense`	$299.87K	USD	2 Qtrs
Marketing expenses	`MarketingExpense`	-	USD	1 Quarter
Marketing expenses	`MarketingExpense`	-	USD	2 Qtrs
Marketing expenses	`MarketingExpense`	$289.07K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$348.67K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$177.90K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$475.84K	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$79.49K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.60M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$679.90K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-600.46K	USD	2 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-153.63K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-225.48K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-258.73K	USD	2 Qtrs
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	-	USD	1 Quarter
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$-873.83K	USD	2 Qtrs
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	-	USD	2 Qtrs
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$-922.02K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$5.81K	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$3.06K	USD	Point-in-time
Interest (expense)	`InterestExpense`	$250.00	USD	1 Quarter
Interest (expense)	`InterestExpense`	$649.61K	USD	2 Qtrs
Interest (expense)	`InterestExpense`	$2.75K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-156.38K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-376.24K	USD	2 Qtrs
Net Income (Loss)	`ProfitLoss`	$696.29K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-264.54K	USD	2 Qtrs
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-68.92K	USD	2 Qtrs
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.52K	USD	2 Qtrs
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-41.19K	USD	1 Quarter
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$43.59K	USD	1 Quarter
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-199.98K	USD	1 Quarter
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$737.49K	USD	1 Quarter
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-307.32K	USD	2 Qtrs
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-262.02K	USD	2 Qtrs
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.01	USD	2 Qtrs
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.01	USD	2 Qtrs
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.17M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	39.22M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.34M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	40.85M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.17M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.22M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.34M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	47.25M	shares	1 Quarter

Cash Flow Statement 71 line items

Line Item	Tag	Value	Unit	Period
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-199.98K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$737.49K	USD	1 Quarter
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-307.32K	USD	2 Qtrs
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-262.02K	USD	2 Qtrs
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-68.92K	USD	2 Qtrs
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.52K	USD	2 Qtrs
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-41.19K	USD	1 Quarter
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$43.59K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-156.38K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-376.24K	USD	2 Qtrs
Net (Loss)	`ProfitLoss`	$696.29K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-264.54K	USD	2 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	2 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	$-873.83K	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	-	USD	2 Qtrs
Bad debt recovery	`ProvisionForDoubtfulAccounts`	$-44.54K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$25.04K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$81.56K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Loss on settlement of notes and other payables	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on settlement of notes and other payables	`GainsLossesOnExtinguishmentOfDebt`	$-634.33K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$113.52K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	-	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$118.56K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$79.69K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$230.00K	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$160.83K	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$296.64K	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$30.34K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-2.25K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Product deposit	`IncreaseDecreaseInDeposits`	-	USD	2 Qtrs
Product deposit	`IncreaseDecreaseInDeposits`	$-74.04K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-32.82K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$118.20K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-138.88K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$254.16K	USD	2 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-76.66K	USD	2 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-512.57K	USD	2 Qtrs
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$63.38K	USD	2 Qtrs
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$79.13K	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$309.04K	USD	2 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	2 Qtrs
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	$100.00K	USD	2 Qtrs
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	-	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$176.42K	USD	2 Qtrs
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	-	USD	2 Qtrs
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$673.24K	USD	2 Qtrs
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-3.15K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$79.13K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$766.09K	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.47K	USD	2 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$253.53K	USD	2 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$235.45K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$436.09K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$235.45K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$436.09K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$3.61K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaid`	$5.81K	USD	2 Qtrs
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	$242.19K	USD	2 Qtrs
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	-	USD	2 Qtrs
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	-	USD	2 Qtrs
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	$272.20K	USD	2 Qtrs
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	-	USD	2 Qtrs
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	$1.64M	USD	2 Qtrs

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-433.69K	USD	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$230.00K	USD	2 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$84.17K	USD	1 Quarter
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$160.83K	USD	2 Qtrs
Sale of common stock and warrants	`StockIssuedDuringPeriodValueNewIssues`	$673.25K	USD	2 Qtrs
Conversion of non-controlling interest equity for shares and warrants	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	2 Qtrs
Conversion of note payable	`StockIssuedDuringPeriodValueOther`	$745.41K	USD	2 Qtrs
Conversion of accrued expenses	`StockIssuedDuringPeriodValueConversionOfAccruedExpenses`	$131.10K	USD	2 Qtrs
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$56.52K	USD	2 Qtrs
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$58.75K	USD	Point-in-time
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	250,000.00	shares	Point-in-time
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	62,500.00	shares	3 Qtrs
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$-3.15K	USD	2 Qtrs
Issuance of stock options for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$113.52K	USD	2 Qtrs
Investment in subsidiary by noncontrolling interest, net of distributions	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$63.38K	USD	2 Qtrs
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationReclassificationOfOptionsWarrantsAndOtherContractsFromEquityToDerivativeLiabilities`	$-1.64M	USD	2 Qtrs
Net (loss)	`ProfitLoss`	$-156.38K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-376.24K	USD	2 Qtrs
Net (loss)	`ProfitLoss`	$696.29K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-264.54K	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-433.69K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.